← Back to Search

Clinical Decision Support Tool for Migraine (CDST Trial)

N/A
Waitlist Available
Led By Elizabeth Seng, PhD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 of the treatment
Awards & highlights

CDST Trial Summary

This study is evaluating whether a tailored decision support tool may help improve adherence to migraine management strategies.

Eligible Conditions
  • Migraine

CDST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 of the treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 of the treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to Acute Migraine Management Strategies: Overuse
Adherence to Acute Migraine Management Strategies: Treat Early
Adherence to Preventive Behavioral Strategies
Secondary outcome measures
Adherence to preventive medication
Average head pain
Headache days
+3 more

CDST Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Clinical Decision Support ToolExperimental Treatment1 Intervention
Tailored education provided via a smartphone application
Group II: Headache EducationActive Control1 Intervention
Non-tailored education provided via a smartphone application.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinical Decision Support Tool
2009
N/A
~1580

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,340 Previous Clinical Trials
649,302 Total Patients Enrolled
7 Trials studying Migraine
1,185 Patients Enrolled for Migraine
Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,857,051 Total Patients Enrolled
4 Trials studying Migraine
300 Patients Enrolled for Migraine
Elizabeth Seng, PhDPrincipal InvestigatorAlbert Einstein College of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025